86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,181 / 薬物数 : 701 - (DrugBank : 126) / 標的遺伝子数 : 105 - 標的パスウェイ数 : 192

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04207593 (ClinicalTrials.gov)	April 1, 2019	17/12/2019	The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia	Prospective, Randomized, Controlled Trial of the Effect of Long-term OxygenTherapy on 6-minute Walki ...	Oxygen Deficiency;Pulmonary Arterial Hypertension;CTEPH	Drug: Oxygen	Heidelberg University	NULL	Recruiting	18 Years	N/A	All	40	Phase 2	Germany
2	EUCTR2018-001387-39-DE (EUCTR)	15/03/2019	30/01/2019	The effect of oxygen therapy in patients with pulmonary Hypertension.	A prospective, randomized, controlled trial to assess the effect of long-term oxygentherapy on 6-min ...	pulmonary arterial hypertension (PAH) and chronic thromboembolicpulmonary hypertension (CTEPH);Thera ...	Trade Name: Oxygen , liquid INN or Proposed INN: OXYGEN Other descriptive name: Sauerstoff	Thoraxklinik-Heidelberg gGmbH	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	Germany
3	NCT03683082 (ClinicalTrials.gov)	June 5, 2018	20/9/2018	Oxygen Treatment and Pulmonary Arterial Hypertension	Acute Effects of Oxygen Supplementation Among Pulmonary Arterial Hypertension Patients	Pulmonary Arterial Hypertension	Drug: Oxygen supplementation;Drug: Sham O2 (medical air)	George Papanicolaou Hospital	NULL	Unknown status	18 Years	80 Years	All	10	N/A	Greece
4	NCT02661802 (ClinicalTrials.gov)	January 2012	20/1/2016	Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger Syndrome	Acute Effects of 40% OxygenSupplementation Determined Better Exercise Capacity in Eisenmenger Syndro ...	Eisenmenger Complex;Hypertension, Pulmonary	Other: Oxygen Supplementation	Federal University of São Paulo	NULL	Completed	18 Years	60 Years	Both	30	N/A	NULL
5	NCT00626028 (ClinicalTrials.gov)	September 2004	20/2/2008	Comparison of Inhaled Nitric Oxide and Oxygenin Participants Reactivity During Acute Pulmonary Vasod ...	Comparison of Supplemental Oxygenand Nitric Oxide for Inhalation Plus Oxygenin the Evaluation of the ...	Idiopathic Pulmonary Arterial Hypertension;Cardiomyopathy	Drug: Nitric Oxide for inhalation;Drug: Oxygen;Drug: Nitric Oxide plus Oxygen	Mallinckrodt	NULL	Completed	N/A	18 Years	All	136	Phase 3	United States;France;Netherlands;Spain;United Kingdom
6	NCT00317486 (ClinicalTrials.gov)	September 2003	21/4/2006	Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology	A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Tracle ...	Pulmonary Arterial Hypertension Related to Eisenmenger Physiology	Drug: bosentan	Actelion	NULL	Completed	12 Years	N/A	Both	54	Phase 4	United States;Australia;Austria;Belgium;Canada;France;Germany;Italy;Netherlands;Spain;United Kingdom ...

First Previous1Next Last